Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA254102
Max Phase: Preclinical
Molecular Formula: C30H40O5
Molecular Weight: 480.65
Molecule Type: Small molecule
Associated Items:
ID: ALA254102
Max Phase: Preclinical
Molecular Formula: C30H40O5
Molecular Weight: 480.65
Molecule Type: Small molecule
Associated Items:
Synonyms (2): 6-Oxo-Pristimerol | 6-Oxopristimerol
Synonyms from Alternative Forms(2):
Canonical SMILES: COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC(=O)c5c(cc(O)c(O)c5C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1
Standard InChI: InChI=1S/C30H40O5/c1-17-23-18(14-20(32)24(17)33)28(4)11-13-30(6)22-16-27(3,25(34)35-7)9-8-26(22,2)10-12-29(30,5)21(28)15-19(23)31/h14-15,22,32-33H,8-13,16H2,1-7H3/t22-,26-,27-,28+,29-,30+/m1/s1
Standard InChI Key: QHONUEZGTQYXKH-NLVUKCNFSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: Yes | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 480.65 | Molecular Weight (Monoisotopic): 480.2876 | AlogP: 6.37 | #Rotatable Bonds: 1 |
Polar Surface Area: 83.83 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 8.06 | CX Basic pKa: | CX LogP: 6.26 | CX LogD: 6.18 |
Aromatic Rings: 1 | Heavy Atoms: 35 | QED Weighted: 0.36 | Np Likeness Score: 2.90 |
1. Morita H, Hirasawa Y, Muto A, Yoshida T, Sekita S, Shirota O.. (2008) Antimitotic quinoid triterpenes from Maytenus chuchuhuasca., 18 (3): [PMID:18164197] [10.1016/j.bmcl.2007.12.016] |
2. Shirota O, Morita H, Takeya K, Itokawa H.. (1994) Cytotoxic aromatic triterpenes from Maytenus ilicifolia and Maytenus chuchuhuasca., 57 (12): [PMID:7714534] [10.1021/np50114a009] |
3. Chang FR, Hayashi K, Chen IH, Liaw CC, Bastow KF, Nakanishi Y, Nozaki H, Cragg GM, Wu YC, Lee KH.. (2003) Antitumor agents. 228. five new agarofurans, Reissantins A-E, and cytotoxic principles from Reissantia buchananii., 66 (11): [PMID:14640511] [10.1021/np030241v] |
Source(1):